Nutraceuticals Market Potential Still Piques J&J's Interest
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson remains committed to building a presence in the nutraceuticals market despite the slow start of its Benecol franchise in the U.S., Chairman and CEO Ralph Larsen reaffirmed during an analysts' conference call on year-end financial results Jan. 25.
You may also be interested in...
J&J Supplement Offerings Grow With McNeil Aflexa Launch
Johnson & Johnson is adding to its portfolio of dietary supplements and functional foods with the introduction of McNeil Consumer Healthcare's Aflexa glucosamine dietary supplement in Florida.
J&J Supplement Offerings Grow With McNeil Aflexa Launch
Johnson & Johnson is adding to its portfolio of dietary supplements and functional foods with the introduction of McNeil Consumer Healthcare's Aflexa glucosamine dietary supplement in Florida.
J&J Supplement Offerings Grow With McNeil Aflexa Launch
Johnson & Johnson is adding to its portfolio of dietary supplements and functional foods with the introduction of McNeil Consumer Healthcare's Aflexa glucosamine dietary supplement in Florida.